MEDPACE HOLDINGS INC

NASDAQ: MEDP (Medpace Holdings, Inc.)

Last update: 6 days ago, 11:25AM

474.01

1.07 (0.23%)

Previous Close 472.94
Open 473.65
Volume 95,523
Avg. Volume (3M) 498,676
Market Cap 13,316,363,264
Price / Earnings (TTM) 35.16
Price / Earnings (Forward) 34.84
Price / Sales 6.62
Price / Book 77.51
52 Weeks Range
250.05 (-47%) — 501.30 (5%)
Earnings Date 20 Oct 2025
Profit Margin 19.31%
Operating Margin (TTM) 20.32%
Diluted EPS (TTM) 13.10
Quarterly Revenue Growth (YOY) 9.30%
Quarterly Earnings Growth (YOY) 11.70%
Total Debt/Equity (MRQ) 25.33%
Current Ratio (MRQ) 0.730
Operating Cash Flow (TTM) 581.97 M
Levered Free Cash Flow (TTM) 433.28 M
Return on Assets (TTM) 15.44%
Return on Equity (TTM) 65.82%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Mixed Mixed
Diagnostics & Research (Global) Mixed Mixed
Stock Medpace Holdings, Inc. Bullish Bullish

AIStockmoo Score

-0.4
Analyst Consensus -1.5
Insider Activity -4.0
Price Volatility -3.0
Technical Moving Averages 2.5
Technical Oscillators 4.0
Average -0.40

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
MEDP 13 B - 35.16 77.51
EXAS 10 B - - 3.64
GH 8 B - - 55.67
RDNT 4 B - - 5.92
VCYT 2 B - 102.58 1.94
NEO 937 M - - 1.33

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Growth
% Held by Insiders 20.55%
% Held by Institutions 91.47%

Ownership

Name Date Shares Held
Td Asset Management Inc 30 Jun 2025 457,645
Epoch Investment Partners, Inc. 30 Jun 2025 445,231
52 Weeks Range
250.05 (-47%) — 501.30 (5%)
Price Target Range
305.00 (-35%) — 510.00 (7%)
High 510.00 (Mizuho, 7.59%) Buy
Median 436.00 (-8.02%)
Low 305.00 (UBS, -35.66%) Sell
Average 426.71 (-9.98%)
Total 1 Buy, 4 Hold, 2 Sell
Avg. Price @ Call 440.35
Firm Date Target Price Call Price @ Call
UBS 29 Jul 2025 305.00 (-35.66%) Sell 447.92
Mizuho 25 Jul 2025 510.00 (7.59%) Buy 447.49
Baird 23 Jul 2025 490.00 (3.37%) Hold 437.41
Barclays 23 Jul 2025 450.00 (-5.07%) Hold 437.41
24 Jun 2025 300.00 (-36.71%) Hold 315.28
Deutsche Bank 23 Jul 2025 430.00 (-9.28%) Hold 437.41
TD Cowen 23 Jul 2025 366.00 (-22.79%) Sell 437.41
Truist Securities 23 Jul 2025 436.00 (-8.02%) Hold 437.41
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
BURWIG SUSAN E - - 0 0
TROENDLE AUGUST J. - 473.48 -620 -293,558
Aggregate Net Quantity -620
Aggregate Net Value ($) -293,558
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 473.48
Name Holder Date Type Quantity Price Value ($)
TROENDLE AUGUST J. Officer 27 Aug 2025 Sell (-) 620 473.48 293,558
BURWIG SUSAN E Officer 26 Aug 2025 Option execute 10,000 - -

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria